Blood filter targets DNA to tame septic shock inflammation
Disease control
Not yet recruiting
This trial tests a device called Nucleocore that removes cell-free DNA (cfDNA) from the blood of people with septic shock. High cfDNA levels are linked to severe inflammation and worse outcomes. The study enrolls adults aged 18-65 with septic shock and elevated cfDNA, and measure…
Phase: NA • Sponsor: Sergey Savko • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC